Butterfly Network, Inc.

Ladies and gentlemen, thank you for standing by. The Butterfly Networks Incorporated fourth quarter 2022 earnings call will take place shortly. Good morning and a warm welcome to the Butterfly Network Incorporated fourth quarter 2022 earnings call. My name is Candice and I will be your moderator for today's call. All lines have been placed on mute during the presentation portion of the call with an opportunity for question and answer at the end. If you would like to ask a question, please press start followed by one on your telephone keypad. I would now like to hand the conferencing Call over to our host, Heather Goetz. The floor is yours. Please go ahead.

Good morning, and thank you for joining us today. Earlier this morning, Butterfly released financial results for the fourth quarter ended December 31st, 2022, and provided a business update. The release and earnings presentation, which include a reconciliation of management's use of non-GAAP financial measures compared to the most recent applicable GAAP measures, are currently available on the investor section of the company's website at ir.butterflynetwork.com. I, Heather Goetz, Executive Vice President and Chief Financial Officer of Butterfly, alongside Dr. Jonathan Rockberg, Butterfly's founder and Interim Chief Executive Officer, and Darius Shahida, Butterfly's Chief Strategy Officer, will host this morning's call. During today's call, we will be making certain forward-looking statements. These statements may include, among other things, expectations with respect to financial results, future performance, development and commercialization of products and services, potential regulatory approvals, the size and potential growth of current or future markets for our products and services, and the impact of the macroeconomic factors on our business. These forward-looking statements are based on current information, assumptions, expectations that are subject to change and involve a number of known and unknown risks. uncertainties and other factors that may cause actual results to differ materially from those contained in the forward-looking statements. These and other risks are described in our filings made with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, and the company disclaims any obligation to update such statements. As a reminder, this call is being webcast live and recorded and we will be referencing a slide presentation in conjunction with our remarks. There may be a short delay between the live telephone audio and the presentation being shown. To access the webcast, please visit the event section in the investor section of our website and a replay of the event will be available following the call. I would now like to turn the call over to Dr. Rothberg. Jonathan.

Thank you Heather and good morning. Since this is the first time many of you have heard from me as interim CEO, I wanted to start today's call by sharing with you why I'm so passionate about Butterfly and why I believe this is our most impactful time since I founded the company a decade ago. I spent my career building disruptive solutions to improve the lives of those I love. I founded Butterfly with a mission to democratize healthcare by making medical imaging accessible to everyone. Currently, two thirds of the world's population lacks access to medical imaging. The team at Butterfly is changing this. Butterfly is the only handheld whole body ultrasound scanner. Paired with leading edge AI, We empower healthcare professionals to make better clinical decisions. Butterfly's growing impact is uniquely enabled by the ease of use of our solution, which started with the invention of the world's first ultrasound technology and is now paired with powerful AI and enterprise software to make clinical work easy. Edify's solution to medical imaging is used by tens of thousands of practitioners across the globe to touch the lives of millions of patients. From health systems in the U.S. and Europe to remote conflict areas and acute crises, including the recent earthquake in Turkey and Syria, practitioners are using Butterfly to transform the way they deliver care and save lives. Having started an industry by putting DNA sequencing on a chip, I can confidently say that Butterfly has forked history and that ultrasound on a chip and AI will become as ubiquitous as a stethoscope and bring medical imaging to the two-thirds of the world that lack it. Butterfly has a world-class leadership team that is executing with more discipline and focus than ever. Our board has formed a search committee and the search is well underway for a full-time CEO. I look forward to updating you on this and other progress in the coming months. I will now turn the call over to Darius to share some of the significant progress we made in 2022.